L R Gowing

Summary

Affiliation: South Australia
Country: Australia

Publications

  1. ncbi request reprint Opioid antagonists and adrenergic agonists for the management of opioid withdrawal
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia, 5067
    Cochrane Database Syst Rev . 2000
  2. ncbi request reprint Substitution treatment of injecting opioid users for prevention of HIV infection
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia, 5063
    Cochrane Database Syst Rev . 2004
  3. ncbi request reprint Buprenorphine for the management of opioid withdrawal
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia, 5063
    Cochrane Database Syst Rev . 2004
  4. ncbi request reprint Alpha2 adrenergic agonists for the management of opioid withdrawal
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia, 5063
    Cochrane Database Syst Rev . 2004
  5. ncbi request reprint Alpha2 adrenergic agonists for the management of opioid withdrawal
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia
    Cochrane Database Syst Rev . 2003
  6. ncbi request reprint Buprenorphine for the management of opioid withdrawal
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia, 5063
    Cochrane Database Syst Rev . 2002
  7. ncbi request reprint Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia, 5063
    Cochrane Database Syst Rev . 2002
  8. ncbi request reprint Opioid antagonists with minimal sedation for opioid withdrawal
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia, 5063
    Cochrane Database Syst Rev . 2002
  9. ncbi request reprint Alpha2 adrenergic agonists for the management of opioid withdrawal
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia, 5063
    Cochrane Database Syst Rev . 2001
  10. ncbi request reprint Opioid antagonists under sedation or anaesthesia for opioid withdrawal
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia, 5063
    Cochrane Database Syst Rev . 2001

Detail Information

Publications16

  1. ncbi request reprint Opioid antagonists and adrenergic agonists for the management of opioid withdrawal
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia, 5067
    Cochrane Database Syst Rev . 2000
    ..As such, managed withdrawal is an essential component of an effective treatment system. This review is one of a series that aims to assess the evidence as to the effectiveness of approaches to managing opioid withdrawal...
  2. ncbi request reprint Substitution treatment of injecting opioid users for prevention of HIV infection
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia, 5063
    Cochrane Database Syst Rev . 2004
    ..Injecting drug users are vulnerable to infection with HIV and other blood borne viruses as a result of collective use of injecting equipment as well as sexual behaviour...
  3. ncbi request reprint Buprenorphine for the management of opioid withdrawal
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia, 5063
    Cochrane Database Syst Rev . 2004
    ..It may also represent the end point of long-term opioid replacement treatment such as methadone maintenance. The availability of managed withdrawal is essential to an effective treatment system...
  4. ncbi request reprint Alpha2 adrenergic agonists for the management of opioid withdrawal
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia, 5063
    Cochrane Database Syst Rev . 2004
    ..It may also represent the end point of long-term treatment such as methadone maintenance. The availability of managed withdrawal is essential to an effective treatment system...
  5. ncbi request reprint Alpha2 adrenergic agonists for the management of opioid withdrawal
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia
    Cochrane Database Syst Rev . 2003
    ..It may also represent the end point of long-term treatment such as methadone maintenance. The availability of managed withdrawal is essential to an effective treatment system...
  6. ncbi request reprint Buprenorphine for the management of opioid withdrawal
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia, 5063
    Cochrane Database Syst Rev . 2002
    ..It may also represent the end point of long-term opioid replacement treatment such as methadone maintenance. The availability of managed withdrawal is essential to an effective treatment system...
  7. ncbi request reprint Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia, 5063
    Cochrane Database Syst Rev . 2002
    ..It may also represent the end point of long-term opioid replacement treatment such as methadone maintenance. The availability of managed withdrawal is essential to an effective treatment system...
  8. ncbi request reprint Opioid antagonists with minimal sedation for opioid withdrawal
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia, 5063
    Cochrane Database Syst Rev . 2002
    ..Managed withdrawal (detoxification) is necessary prior to drug-free treatment. It may also represent the end point of long-term opioid replacement treatment such as methadone maintenance...
  9. ncbi request reprint Alpha2 adrenergic agonists for the management of opioid withdrawal
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia, 5063
    Cochrane Database Syst Rev . 2001
    ..It may also represent the end point of long-term treatment such as methadone maintenance. The availability of managed withdrawal is essential to an effective treatment system...
  10. ncbi request reprint Opioid antagonists under sedation or anaesthesia for opioid withdrawal
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia, 5063
    Cochrane Database Syst Rev . 2001
    ..It may also represent the end point of long-term treatment such as methadone maintenance. The availability of managed withdrawal is essential to an effective treatment system...
  11. ncbi request reprint Buprenorphine for the management of opioid withdrawal
    L Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, 161 Greenhill Road, Parkside, SA, Australia, 5067
    Cochrane Database Syst Rev . 2000
    ..As such, managed withdrawal is an essential component of an effective treatment system. This review is one of a series that aims to assess the evidence as to the effectiveness of the variety of approaches to managing opioid withdrawal...
  12. ncbi request reprint Alpha2-adrenergic agonists in opioid withdrawal
    Linda R Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, Parkside, SA, Australia
    Addiction 97:49-58. 2002
    ..This paper presents the main findings of a systematic (Cochrane) review of the effectiveness of alpha2-adrenergic agonists in managing opioid withdrawal...
  13. ncbi request reprint Systematic review processes and the management of opioid withdrawal
    L R Gowing
    Drug and Alcohol Services Council, University of Adelaide, South Australia
    Aust N Z J Public Health 24:427-31. 2000
    ..To assess the diversity of research on the management of opioid withdrawal, identify sources of heterogeneity and provide a context for subsequent systematic reviews to establish evidence-based best practice...
  14. ncbi request reprint Which substitution pharmacotherapy is most effective in treating opioid dependence?
    Linda R Gowing
    Evidence Based Practice Unit, Drug and Alcohol Services Council, Parkside, SA
    Med J Aust 176:493-4. 2002
  15. pmc Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection
    Linda R Gowing
    University of Adelaide and Drug and Alcohol Services, South Australia, Australia
    J Gen Intern Med 21:193-5. 2006
    ..To assess the effects of oral substitution treatment for opioid-dependent injecting drug users on HIV risk behaviors and infections...
  16. ncbi request reprint The place of detoxification in treatment of opioid dependence
    Linda R Gowing
    Drug and Alcohol Services South Australia, Australia
    Curr Opin Psychiatry 19:266-70. 2006
    ..This review summarizes current research on the management of opioid withdrawal and considers the selection of the approach in different situations...